A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : APP / aminopeptidase P

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   APP  (>> Co-occurring Abbreviation)
Long Form:   aminopeptidase P
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 Structure and substrate fingerprint of aminopeptidase P from Plasmodium falciparum. ---
2014 Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema. ACE, AE, C1-INH, NSAID, PAI-1
2014 Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype. ACE, C1-INH, CPN, HAE, OR
2014 The P-loop region of Schlafen 3 acts within the cytosol to induce differentiation of human Caco-2 intestinal epithelial cells. SI, Slfn3
2014 Unveiling aminopeptidase P from Streptomyces lavendulae: molecular cloning, expression and biochemical characterization. ---
2013 Mycoplasma hyopneumoniae in vitro peptidase activities: identification and cleavage of kallikrein-kinin system-like substrates. ---
2013 The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions. ACE, SNP
2011 A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. ACEI, HNF-4
2010 Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. ---
10  2010 Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. ACE
11  2009 A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Col IV, FN, SCr
12  2009 Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. ACE
13  2008 Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. ---
14  2008 pTONA5: a hyperexpression vector in Streptomycetes. PAP
15  2008 The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill. ACE, OCP
16  2007 Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. ---
17  2007 Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. DP4, MALDI-TOF, NPY
18  2006 Cloning, expression, and characterization of aminopeptidase P from the hyperthermophilic archaeon Thermococcus sp. strain NA1. ---
19  2006 Distribution of aminopeptidase P like immunoreactivity in the olfactory system and brain of frog, Microhyla ornate. DAP-P, ir
20  2006 Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. ACEis, HSRs
21  2005 A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. ACEI
22  2005 Aminopeptidase P isozyme expression in human tissues and peripheral blood mononuclear cell fractions. PBMC
23  2005 Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea. ACE, BK
24  2005 Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates. ---
25  2005 Mechanism of vasopeptidase inhibitor-induced plasma extravasation: comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406. ACE, DPP-IV, VPI
26  2005 Proteolytic activity in Encephalitozoon cuniculi sporogonial stages: predominance of metallopeptidases including an aminopeptidase-P-like enzyme. ---
27  2004 Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. L-NAME, TTC
28  2003 A continuous fluorimetric assay for aminopeptidase P detailed analysis of product inhibition. ---
29  2002 Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. ACEI, DPP-IV
30  2002 Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. ACE, BK, CPN, SPA
31  2001 Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. AAR, ACE, IS
32  2001 Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. ACE, BK, HK
33  2001 Functional expression and characterization of the cytoplasmic aminopeptidase P of Caenorhabditis elegans. ---
34  2001 Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats. ACE, CPN, SHR, WKY
35  2000 Cloning, expression, and characterization of human cytosolic aminopeptidase P: a single manganese(II)-dependent enzyme. RACE
36  2000 Different inhibition of enalaprilat and imidaprilat on bradykinin metabolizing enzymes. ACE, BK, CPN, NEP
37  2000 Identification of critical residues in the active site of porcine membrane-bound aminopeptidase P. ---
38  2000 Potentiation of the vascular response to kinins by inhibition of myocardial kininases. ACE, BK
39  2000 Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases. CS-N, DP II, DP IV, POP, Pyrr, Thia
40  1999 Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. ---
41  1999 Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. ACE, BK, HSR
42  1999 Structural requirements for B2-agonists with improved degradation stability. ACE, APM, BK, CPN
43  1998 Aminopeptidase P--a cell-surface antigen of endothelial and lymphoid cells: catalytic and immuno-histotopical evidences. NPY
44  1997 Evaluation of some fluorogenic substrates for continuous assay of aminopeptidase P. ---
45  1997 Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. ACE, BK
46  1996 Chemical modification of porcine kidney aminopeptidase P indicates the involvement of two critical histidine residues. DEP
47  1996 Inhibition and metal ion activation of pig kidney aminopeptidase P. Dependence on nature of substrate. ACE
48  1996 Molecular cloning and expression in COS-1 cells of pig kidney aminopeptidase P. GPI
49  1995 Potentiation by aminopeptidase P of blood pressure response to bradykinin. ACEI, AUC
50  1994 Release of GPI-anchored membrane aminopeptidase P by enzymes and detergents has some peculiarities. GPI, PI-PLC's
51  1992 Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P. ACE, BK, CPN
52  1991 Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P. ACE, BK, CPN, MERGETPA